The Pharmacotherapy of Inflammatory Bowel Disease in Child and Adolescence
Article information
J Korean Med Assoc. 2010;53(6):524-530
Publication date (electronic) : 2010 June 30
doi :
https://doi.org/10.5124/jkma.2010.53.6.524
Abstract
The importance of pediatric inflammatory bowel disease (IBD) has grown significantly, for the incidence of pediatric inflammatory bowel disease in Korea has been rapidly increasing in recent years. One quarter of the new IBD patients has been known to be presented in childhood. Growth and pubertal delay are one of key factors in the management of pediatric IBD. The focus of treatment in children should be to reduce or eliminate symptoms, optimize nutritional status and growth, and prevent complications. This review will deal with the evidence supporting the treatments currently used in children with inflammatory bowel disease.
References
1. Kim BJ, Song SM, Kim KM, Lee YJ, Rhee KW, Jang JY, Park SJ, Yoon CH. Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: A single-center experience. Dig Dis Sci 2009. (Epub ahead of print).
2. Suh HA, Kim SE, Jang JY, Kim BJ, Kim JS, Lee SY, Chang SH, Kim KM. Efficacy of nutritional therapy in children with Crohn disease. Korean J Pediatr Gastroenterol Nutr 2006. 9210–217.
3. Kim KM. The treatment of pediatric inflammatory bowel disease. Korean J Pediatr Gastroenterol Nutr 2008. 11S. 72–79.
4. Song SM, Jang JY, Kim KM. Nutritional status of childhood onset inflammatory bowel disease. Clinical Nutrition 2008. 196(A)
Article information Continued
Copyright © 2010 Korean Medical Association
